Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Xiongdan Wan on Patients With Major Depressive Disorder : a Single-arm, Non-randomized, Open-label Trial

NCT05136365 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.

NCT NCT05136365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05136365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Xiongdan Wan on Patients With Major Depressive Disorder : a Single-arm, Non-randomized, Open-label Trial
Lead sponsor
Shanghai Mental Health Center
Phase
Phase 2
Overall status
Completed
Start date
December 28, 2021
Completion date
August 30, 2022
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder